2005•The Journal of UrologyRequires access

Marked Suppression of Dihydrotestosterone in Men With Benign Prostatic Hyperplasia by Dutasteride, a Dual 5Alpha-Reductase Inhibitor

Steven A. Kaplan

Abstract

No AccessJournal of UrologyUrological Survey: Benign Prostatic Hyperplasia1 Feb 2005Marked Suppression of Dihydrotestosterone in Men With Benign Prostatic Hyperplasia by Dutasteride, a Dual 5Alpha-Reductase Inhibitor Steven A. KaplanM.D. Steven A. KaplanSteven A. Kaplan More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)60528-9AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Marked Suppression of Dihydrotestosterone in Men With Benign Prostatic Hyperplasia by Dutasteride, a Dual 5Alpha-Reductase Inhibitor." The Journal of Urology, 173(2), pp. 514–515 © 2005FiguresReferencesRelatedDetails Volume 173Issue 2February 2005Page: 514-515 Advertisement Copyright & Permissions© 2005MetricsAuthor Information Steven A. Kaplan More articles by this author Expand All Advertisement PDF downloadLoading ...

About this research paper

What this paper is about

Why it matters

OpenAlex reports 34 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Dutasteride, Dihydrotestosterone, Medicine, Hyperplasia, 5 Alpha-Reductase Inhibitor, Urology, Finasteride, Testosterone (patch)